PubMed Health⌕ Search

Biomedical subjects

C Mangone

Publications and source records attributed to C Mangone.

8 recordsLinked to original sources

Comparison of clinical and pathological phenotypes in two ethnically and geographically unrelated pedigrees segregating an equivalent presenilin 1 mutation.

At least 30 different missense mutations have been identified within the presenilin 1 (PS1) gene in pedigrees transmitting familial Alzheimer's disease. The authors investigated the clinical and pathological features of affected members of two pedigrees segregating a PS1 Met146Leu mutation. Genetic relationships between these pedigrees can be effectively excluded on the basis of genealogical data and the fact that although the amino acid substitution is identical, the nucleotide mutations are different. The clinical picture shows remarkable similarities in the neurological and the neuropathological findings between the two pedigrees. This general clinical and pathological concordance argues that much of the disease phenotype arises directly from the effects of the amino acid substitution within the PS1 protein itself. Clinical differences could arise from a direct effect of the difference in base sequence or, alternatively, from the effect of genetic or environmental modifiers.

Alzheimer Disease↗

Polymerase chain reaction used to detect candidemia in patients with candiduria.

OBJECTIVES: Candiduria has been shown to be an early marker of disseminated fungal infection in critically ill patients who have undergone surgery. The management of candidemia and disseminated candidiasis depends on rapid and definitive identification of Candida. Routine or fungus-specific blood cultures are unreliable and require a large quantity of blood for incubation. We describe the importance of the polymerase chain reaction (PCR) procedure in the early detection of candidemia in critically ill patients who develop candiduria and the favorable outcome in treating these patients with systemic antifungal therapy. METHODS: We compared the results of cultures and PCR to detect the presence of C. albicans in the blood of two critically ill patients with clinical candidiasis and candiduria. RESULTS: PCR detected the presence of C. albicans deoxyribonucleic acid (DNA) in urine and blood specimens of both patients in spite of negative blood cultures and did not detect fungal DNA after systemic antifungal therapy. CONCLUSIONS: Candiduria manifests as an early sign of candidemia, and systemic antifungal therapy timed appropriately based on the clinical condition and onset of candiduria will improve outcome. Detection of fungal DNA in blood by PCR is of value in establishing the diagnosis. Additional studies with a larger sample size are required to evaluate the specificity and sensitivity of PCR as a routine diagnostic test for candidemia.

Aged↗

Treatment of Tourette's syndrome with calcium antagonists.

Six males and one female with chronic tic disorders, whose ages ranged from 12 to 31 years, were evaluated before treatment, after 1 month on placebo, after a single 10 mg nifedipine dose (three patients), and monthly while on flunarizine 10-15 mg (mean dose of 13 mg). None of the patients receiving nifedipine improved, but treatment with flunarizine significantly decreased both motor and phonic tic severity and frequency in all but one patient. Side effects included mild transient headaches in one patient, depression in one, and bradykinesia in two. Although a double-blind study is essential to validate our findings, results suggest that flunarizine is a useful drug in the treatment of Gilles de la Tourette syndrome.

Adolescent↗

Hereditary essential tremor in Buenos Aires (Argentina).

A descriptive trial of essential tremor in Buenos Aires city is proposed. It may be considered as the first one like this in Latin America. During a 15 year period, sixteen families with essential tremor diagnosis have been examined, making a total of 39 patients (20 males and 19 females). The disease was basically studied from its semiological, clinico-evolutive and therapeutical view point, following a protocol. Our results indicate -- a. The clinico-evolutive characteristics: its frequency (according to race, sex, social status, age of beginning and physiopathological type), morbidity and mortality, evolution, prognosis, triggering factors, longevity and multiparity. b. The different treatment given to our patients with discussion of their pharmacokinetic and pharmacodynamic basis and evaluation of the best responses. In this matter, it is concluded that both primidone (750 mg/daily) and/or propranolol (160-240 mg/daily) are undeniably the drugs of first choice for the treatment of this disease. A comparison of the clinico-therapeutic features of this tremor in Buenos Aires and other cities is done. The study of this syndrome in Buenos Aires does not give different results from those obtained in Europe and USA.

Argentina↗